Pathstone Family Office’s Repligen RGEN Stock Holding History

Pathstone Family Office’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$897K	Buy	5,641 +1,554	+38%	+$254K	0.01%	763
2023 Q2	$578K	Buy	4,087 +2,598	+174%	+$417K	0.01%	696
2023 Q1	$279K	Sell	1,489 -6,941	-82%	-$1.24M	﹤0.01%	948
2022 Q4	$1.17M	Buy	8,430 +595	+8%	+$108K	0.01%	721
2022 Q3	$1.47M	Buy	7,835 +6,131	+360%	+$1.29M	0.01%	551
2022 Q2	$277K	Buy	1,704 +101	+6%	+$16K	0.01%	832
2022 Q1	$439K	Buy	1,603 +186	+13%	+$35.3K	0.01%	595
2021 Q4	$375K	Buy	+1,417	New	+$382K	0.01%	645
2021 Q1	–	Sell	-3	Closed	-$1K	–	1195
2020 Q4	$1K	Hold	3	–	–	﹤0.01%	1112
2020 Q3	$0	Sell	3 -3	-50%	-$429	﹤0.01%	958
2020 Q2	$0	Buy	+6	New	+$706	﹤0.01%	922

Other funds holding RGEN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Pathstone Family Office's RGEN Position: Q3 2023 in Review

Pathstone Family Office increased its Repligen (RGEN) stake by 38% in Q3 2023, buying an estimated $254K and bringing the position to 5,641 shares worth $897K. The position accounts for 0.01% of the portfolio, ranked #763.

Pathstone Family Office first reported a position in RGEN in Q2 2020 and has held it in 11 quarters since. The position peaked at $1.47M in Q3 2022. 440 funds tracked by Wall St. Rank hold RGEN as of Q3 2023.

Pathstone Family Office held 5,641 shares of Repligen worth $897K as of Q3 2023.
Pathstone Family Office bought 1,554 Repligen shares in Q3 2023, an estimated $254K.
Repligen made up 0.01% of Pathstone Family Office's portfolio in Q3 2023, its #763 holding.
Pathstone Family Office first reported a position in Repligen in Q2 2020 and has held it in 11 quarters since.
Pathstone Family Office's Repligen position peaked at $1.47M in Q3 2022.
440 funds tracked by Wall St. Rank held Repligen as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.